S545-0657 Screening compound: 1-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]azepan-1-yl}ethan-1-one

S545-0657 Screening compound: 1-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]azepan-1-yl}ethan-1-one
S545-0657 Screening compound: 1-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]azepan-1-yl}ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S545-0657
1-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]azepan-1-yl}ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S545-0657

Molecular Formula

C15H18N4O2 (C15 H18 N4 O2)

Compound Name

1-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]azepan-1-yl}ethan-1-one

IUPAC name

1-{2-[3-(pyridin-4-yl)-124-oxadiazol-5-yl]azepan-1-yl}ethan-1-one

SMILES

CC(N(CCCCC1)C1c1nc(-c2ccncc2)no1)=O

InChI

InChI=1S/C15H18N4O2/c1-11(20)19-10-4-2-3-5-13(19)15-17-14(18-21-15)12-6-8-16-9-7-12/h6-9,13H,2-5,10H2,1H3/t13-/m0/s1

InChI Key

GZAQFXRBZUBKMH-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD30462774

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

286.33

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.191

Distribution Coefficient, logD

2.191

Water Solubility, LogSw

-1.96

Polar Surface Area

58.485

Acid Dissociation Constant (pKa)

24.63

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.67

S545-0657 in Drug Discovery

Included in Screening Libraries

3D-Fragment Library (4274 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

CNS BBB Library (22607 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Fragments
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with S545-0657 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S545-0657?
Check Price and Availability of S545-0657, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S545-0657 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S545-0657
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S545-0657
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S545-0657 available by request